Embryo Invest ApS: Financial statements 2021
CVR: 42047864
Source: annual report 2021, Danish Business Authority
15/01/2021 – 31/12/2021
Embryo Invest ApS (CVR 42047864) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -5,000 and a net result of DKK 6,293,474. Equity in the 2021 report amounted to DKK 6,343,474. The solvency ratio was 54.4%.
- Gross Profit
- DKK -5,000
- Profit/Loss
- DKK 6,293,474
- Equity
- DKK 6,343,474
- Total Assets
- DKK 11,652,474
- Employees
- 0
Official annual report
Find more companies like Embryo Invest ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of January 15, 2021, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Embryo Invest ApS.
As of January 15, 2021, Cathrine Olesen Emborg is registered as director of Embryo Invest ApS.
As of January 15, 2021, Cathrine Olesen Emborg is registered as an owner of Embryo Invest ApS with an ownership share of 100%.
Embryo Invest ApS was founded on January 15, 2021.
About Embryo Invest ApS
Embryo Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Cathrine Olesen Emborg. The company is owned by Cathrine Olesen Emborg. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -5,449 and a net result of DKK 840,493 compared with DKK 8,570,903 the year before. Equity in the 2025 report amounted to DKK 12,423,903.
